İ. Yalcin Et Al. , "Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment.," International journal of clinical oncology , vol.23, no.2, pp.329-337, 2018
Yalcin, İ. Et Al. 2018. Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment.. International journal of clinical oncology , vol.23, no.2 , 329-337.
Yalcin, İ., Meydanli, M. M., Turan, A. T., Taskin, S., Sari, M. E., Gungor, T., ... Akbayir, O.(2018). Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment.. International journal of clinical oncology , vol.23, no.2, 329-337.
Yalcin, İBRAHİM Et Al. "Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment.," International journal of clinical oncology , vol.23, no.2, 329-337, 2018
Yalcin, İBRAHİM Et Al. "Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment.." International journal of clinical oncology , vol.23, no.2, pp.329-337, 2018
Yalcin, İ. Et Al. (2018) . "Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment.." International journal of clinical oncology , vol.23, no.2, pp.329-337.
@article{article, author={İBRAHİM YALÇIN Et Al. }, title={Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment.}, journal={International journal of clinical oncology}, year=2018, pages={329-337} }